BioBridge Global CEO Marty Landon recently sat down with editors from Invest: San Antonio magazine for a Q and A on how the organization is meeting the demand for local healthcare and the growing advanced therapies market in today’s economic climate.
MasterControl has published a case study of its experience with BioBridge Global to demonstrate the effectiveness and abilities of its quality control and manufacturing solutions software in the advanced therapies industry.
South Texas Blood & Tissue, a subsidiary of San Antonio nonprofit BioBridge Global, is part of the Be The Match BioTherapies Cord Blood Bank Alliance that will provide research grade and cGMP umbilical cord blood units as a starting material for researchers and therapeutic developers.
South Texas Blood & Tissue has been presented the 2023 Partnership Recognition Award by the Texas Division of Emergency Management.
San Antonio and its surrounding areas are ripe for investment and opportunity, according to several city business leaders who presented at the Invest: San Antonio 2022-23 Leadership Summit.
South Texas Blood & Tissue’s Executive Director of Blood Operations, Audra Taylor, presented on the impact of the Heroes in Arms program to supply emergency vehicles and trauma centers with whole blood units in an online seminar during Blood Advocacy Week.
More than 20 startups and investment groups toured BioBridge Global on April 18 to learn how the organization supports the development of advanced therapies.
To combat blood shortages, South Texas Blood & Tissue’s Medical Director proposed the latest ways for hospitals and blood centers to work together. Dr.
BioBridge Global recently gave a tour of subsidiary GenCure to Blood Centers of America Advanced Therapies Network.
In February, BioBridge Global hosted RegenMedSA’s annual conference featuring regenerative medicine related research and innovatio